Senior insider sale
Chief Development Officer at RAPPORT THERAPEUTICS, INC. — senior position signals high conviction
$995.1K
30.34K shares
What this filing means
YELESWARAM KRISHNASWAMY plans to sell 30.34K shares of RAPPORT THERAPEUTICS, INC. valued at approximately $995.1K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 4/13/2026ACC: 0001950047-26-003401
Officer· Chief Development Officer
Since Feb 2026
30.34K
Shares to sell
$995.1K
Approx. market value
19.36K
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months1
Founders Shares
N/A
7/20/2025
19.36KTotal acquired19.36K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
7/20/2025 | Founders Shares N/A | 19.36K | — |
| Total | 19.36K | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
500.00
Market value
$17.5K
4/10/2026
—Completed
Units to sell
360.00
Market value
$12.6K
4/8/2026
—Completed
Units to sell
10.12K
Market value
$303.4K
3/25/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
19.36K
Market value
$661.7K
4/13/2026
Total
Units
30.34K
Value
$995.1K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
4/10/2026 | 500.00 | $17.5K | — | Completed |
4/8/2026 | 360.00 | $12.6K | — | Completed |
3/25/2026 | 10.12K | $303.4K | — | Completed |
| Planned — Approximate Date | ||||
4/13/2026 | 19.36K | $661.7K | NASDAQ | Planned |
| Total | 30.34K | $995.1K | ||